We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$40.1B
AUM Growth
-$4.93B
(-11%)
Cap. Flow
-$4.88B
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
959
New
32
Increased
238
Reduced
614
Closed
39
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$192M |
| 2 |
Fiserv Inc
FISV
|
+$93.4M |
| 3 |
American Express
AXP
|
+$91.1M |
| 4 |
Prologis
PLD
|
+$86.5M |
| 5 |
AbbVie
ABBV
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$197M |
| 3 |
Apple
AAPL
|
+$164M |
| 4 |
RTN
Raytheon Company
RTN
|
+$154M |
| 5 |
Chevron
CVX
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 15.72% |
| 3 | Consumer Discretionary | 12.22% |
| 4 | Healthcare | 10.98% |
| 5 | Communication Services | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
MGP Ingredients
MGPI
$330M
| $31.3M | 0.08% |
629,363
+110,645
| +21% | +$6.21M |
2019 Q2
1 quarter
|
|
227
US Physical Therapy
USPH
$1.28B
| $31M | 0.08% |
237,154
-50,698
| -18% | -$6.6M |
2017 Q3
8 quarters
|
|
228
General Motors
GM
$73.4B
| $30.9M | 0.08% |
823,897
-20,768
| -2% | -$799K |
2017 Q3
8 quarters
|
|
|
CERN
229
DELISTED
Cerner Corp
CERN
| $30.5M | 0.08% |
446,978
-123,140
| -22% | -$8.72M |
2017 Q3
8 quarters
|
|
230
Wintrust Financial
WTFC
$9.68B
| $30.1M | 0.08% |
465,698
-57,698
| -11% | -$3.83M |
2017 Q3
8 quarters
|
|
231
FedEx
FDX
$69.9B
| $30.1M | 0.08% |
206,486
-2,282
| -1% | -$368K |
2017 Q3
8 quarters
|
|
232
Vornado Realty Trust
VNO
$6.2B
| $30M | 0.07% |
471,140
+233,553
| +98% | +$14.7M |
2017 Q3
8 quarters
|
|
233
Biogen
BIIB
$34.8B
| $30M | 0.07% |
128,787
-89,720
| -41% | -$20.9M |
2017 Q3
8 quarters
|
|
234
Highwoods Properties
HIW
$3.22B
| $30M | 0.07% |
667,391
+247,371
| +59% | +$10.9M |
2017 Q3
8 quarters
|
|
235
J&J Snack Foods
JJSF
$1.47B
| $30M | 0.07% |
156,120
-61,479
| -28% | -$11.2M |
2017 Q3
8 quarters
|
|
236
G-III Apparel Group
GIII
$1.22B
| $29.9M | 0.07% |
1,162,011
-276,060
| -19% | -$6.92M |
2017 Q3
8 quarters
|
|
237
Automatic Data Processing
ADP
$113B
| $29.9M | 0.07% |
185,091
-2,680
| -1% | -$443K |
2017 Q3
8 quarters
|
|
238
Allegion
ALLE
$13.2B
| $29.7M | 0.07% |
286,456
-1,029,511
| -78% | -$105M |
2017 Q3
8 quarters
|
|
239
Progressive
PGR
$124B
| $29.6M | 0.07% |
383,795
-407,873
| -52% | -$32.1M |
2017 Q3
8 quarters
|
|
240
Yum! Brands
YUM
$41.2B
| $29.6M | 0.07% |
260,668
+3,454
| +1% | +$395K |
2017 Q3
8 quarters
|
|
|
BPFH
241
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $29.4M | 0.07% |
2,521,282
-838,685
| -25% | -$9.44M |
2017 Q3
8 quarters
|
|
242
Stryker
SYK
$112B
| $29.4M | 0.07% |
135,778
-5,641
| -4% | -$1.21M |
2017 Q3
8 quarters
|
|
243
WD-40
WDFC
$2.7B
| $29.2M | 0.07% |
159,298
-54,437
| -25% | -$9.79M |
2017 Q3
8 quarters
|
|
244
EXL Service
EXLS
$5.93B
| $29.2M | 0.07% |
2,182,675
-612,005
| -22% | -$8.17M |
2017 Q3
8 quarters
|
|
245
Omega Healthcare
OHI
$13.8B
| $29M | 0.07% |
694,033
+269,059
| +63% | +$10.5M |
2018 Q2
5 quarters
|
|
246
Crown Castle
CCI
$34B
| $28.9M | 0.07% |
207,729
+8,040
| +4% | +$1.11M |
2017 Q3
8 quarters
|
|
247
Valero Energy
VLO
$128B
| $28.8M | 0.07% |
337,665
-114,062
| -25% | -$9.22M |
2017 Q3
8 quarters
|
|
248
Becton Dickinson
BDX
$52.8B
| $28.8M | 0.07% |
116,484
-1,195
| -1% | -$295K |
2017 Q3
8 quarters
|
|
249
Dow Inc
DOW
$21.4B
| $28.3M | 0.07% |
594,131
-26,438
| -4% | -$1.24M |
2019 Q2
1 quarter
|
|
|
HSKA
250
DELISTED
Heska Corp
HSKA
| $28.2M | 0.07% |
397,004
+13,562
| +4% | +$1.02M |
2018 Q1
6 quarters
|
|
Similar funds
Aberdeen Group's Q3 2019 Portfolio in Review
As of Q3 2019, Aberdeen Group held 959 positions worth $40.1B, down 11% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aberdeen Group withdrew a net $4.88B in Q3 2019, closing 39 positions and reducing 614 holdings. Its most notable exit was L3Harris, an estimated $88.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $40.7M.
- Aberdeen Group's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,493,397 shares worth $40.7M.
- Aberdeen Group added most to Fidelity National Information Services in Q3 2019, an estimated $192M increase.
- Aberdeen Group's biggest Q3 2019 reduction was Wells Fargo, cutting an estimated $206M.
- Aberdeen Group fully exited L3Harris in Q3 2019, selling an estimated $88.4M.
- Aberdeen Group's ten largest holdings make up 19% of its $40.1B portfolio in Q3 2019.
- Aberdeen Group opened 32 new positions and closed 39 in Q3 2019.
- Aberdeen Group's portfolio value fell 11% quarter-over-quarter to $40.1B.
Based on Aberdeen Group's 13F filing for Q3 2019, filed 13 Nov 2019.